LANG JAMES PAUL received a stock award from HALOZYME THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001159036-26-000007
Director
Since Dec 2025
+2.23K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.23K acquired
Non-Derivative Transactions1
Restricted Stock Units
Direct
Shares
+889.00
Price / share
—
Trade value
—
% of position
New position
1/2/2026
0.00→889.00
Total
Net shares
+889.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | 1/2/2026 | A · Award | +889.00 | — | — | New position | 0.00 | 889.00 |
| Total | +889.00 | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
1.34K shares
Shares
+1.34K
Strike price
70.31
Held after
1.34K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock1.34K shares | 1/2/2026 | A · Award | +1.34K | 70.31 | — | 1.34K |